Samrat Pharmachem Limited announced its financial results for the quarter ended June 30, 2026. The company reported a profit after tax of ₹87.60 lakh. Revenue from operations for the quarter stood at ₹7,976.10 lakh. The Board of Directors took note of these Un-Audited Standalone Financial Results at a meeting held on August 14, 2026.
Samrat Pharmachem Announces Q1 FY27 Financial Results
Samrat Pharmachem Limited has disclosed its standalone unaudited financial results for the quarter ended June 30, 2026. The company’s Board of Directors reviewed and took on record these results during a meeting held on August 14, 2026.
Key Financial Highlights
For the quarter ended June 30, 2026, Samrat Pharmachem reported the following key figures:
- Revenue From Operations: ₹7,976.10 lakh
- Total Income: ₹8,074.92 lakh
- Total Expenses: ₹7,916.39 lakh
- Profit Before Tax: ₹158.53 lakh
- Profit After Tax: ₹87.60 lakh
The company also reported basic and diluted earnings per equity share of ₹2.84 for the period.
Board Meeting Details
The Board Meeting commenced at 14:00 hours and concluded at 20:00 hours on Friday, August 14, 2026. The attached Un-Audited Standalone Financial Results, along with the Limited Review Report of the Statutory Auditor, were considered and recorded during this meeting.
Source: BSE
